COMAS (Cutaneous Oxygen Monitoring And Stimulation)

Submitted 6 years ago

COMAS (Cutaneous Oxygen Monitoring And Stimulation) is an entirely new approach to the treatment of pressure (and potentially diabetic) ulcers.

The new method for treating pressure ulcers was recently patented and will likely apply to diabetic ulcers - a very large potential market. The patent was granted on July 11, 2017.

Apparatus and method for treating and preventing formation of pressure ulcers
US 9700717 B2
http://www.google.com/patents/US9700717

My research has shown that "pressure" ulcers are not strictly due to unrelieved pressure but to impaired circulatory function and poor tissue perfusion. The idea behind COMAS is therefore to monitor and maintain tissue perfusion at the bodily sites that are most at risk for these ulcers, especially the sacrum, and raise it as needed. This is done by using an oxygen sensor coupled with an electrical stimulator. When the measured oxygen level drops below a set point, an electrical stimulator placed on the back at chest level is automatically activated. The stimulator increases blood flow to the area, raising the level of tissue oxygenation into the desired range, and thereby prevents (and/or treats) pressure and diabetic ulcers

Patients with existing pressure ulcers will be quickly treated and healed, with greatly reduced needs for personal nursing care and repositioning. The end users of COMAS will be severely injured and debilitated patients, the frail elderly, and those with impaired circulatory function; it will be a great cost-saving device and improve the quality of life for both patients and their care-givers.

COMAS will be worn unobtrusively in the bed or wheelchair and will be available either as a vest-like garment or as two separate components (stimulator and sensor), each placed separately on the skin and connected by wi-fi. Parts of the device will be disposable.

Clinical proof-of-concept for the device was obtained in my research on patients with spinal cord injury at the former Charity Hospital, New Orleans. LSU Medical Center gave me the rights to the invention.

A prototype has been developed by an engineering company in Tullahoma, Tennessee (GTL - Gloyer, Taylor, Lewis) and is just weeks from being completed and bench-tested. The work will be completed at MS State University by Prof. Filip To and his team in the Department of Electrical Engineering. Clinical testing will be done at Touro Infirmary in New Orleans. As the device involves standard medical equipment, FDA approval is expected within a few months.

A copy of the draft Business Plan is available upon request.

I hope Honeywell will be interested in manufacturing and marketing the product.

Anthony R Mawson, DrPH
President, Chalfont LLC
Jackson, MS, USA
http://www.chalfontscientificresearch.com
601-622-2597
[email protected]